Pharma giant Merck announces US deal to cut IVF drug prices
DARMSTADT (DPA, CONVERSEER) – German pharmaceutical giant Merck has entered into an agreement with US President Donald Trump’s administration to broaden access to its in vitro fertilization (IVF) therapies. The initiative aims to support over 10 million American women facing fertility challenges, the company said on Thursday. Under the agreement, Merck’s US and Canadian healthcare division,…
